Request for Nominations on the Tobacco Products Scientific Advisory Committee, 64605-64606 [2014-25795]
Download as PDF
Federal Register / Vol. 79, No. 210 / Thursday, October 30, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0383]
Request for Nominations on the
Tobacco Products Scientific Advisory
Committee
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is requesting that
any small business tobacco
manufacturing industry organizations
interested in participating in the
selection of nonvoting industry
representatives to represent the interests
of the small business tobacco
manufacturing industry, to serve on the
Tobacco Products Scientific Advisory
Committee for the Center for Tobacco
Products notify FDA in writing. FDA is
also requesting nominations for
nonvoting industry representatives to be
included in a pool of individuals to
represent the interests of the small
business tobacco manufacturing
industry on the Tobacco Products
Scientific Advisory Committee. A
nominee may either be self-nominated
or nominated by an organization to
serve as a nonvoting industry
representative. This position may be
filled on a rotating, sequential basis by
representatives of different small
business tobacco manufacturers based
on areas of expertise relevant to the
topics being considered by the Advisory
Committee. Nominations will be
accepted for current vacancies effective
with this notice.
DATES: Any small business tobacco
manufacturing industry organization
interested in participating in the
selection of an appropriate nonvoting
member to represent the interests of the
small business tobacco manufacturing
industry, must send a letter stating that
interest to FDA by December 1, 2014
(see sections I and II of this document
for details). Concurrently, nomination
materials for prospective candidates
should be sent to FDA by December 1,
2014.
ADDRESSES: All statements of interest
from small business tobacco
manufacturing industry organizations
interested in participating in the
selection process of nonvoting industry
representative nominations should be
sent to Caryn Cohen (see FOR FURTHER
INFORMATION CONTACT). All nominations
for nonvoting industry representatives
may be submitted electronically by
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:40 Oct 29, 2014
Jkt 235001
accessing the FDA Advisory Committee
Membership Nomination Portal: https://
www.accessdata.fda.gov/scripts/
FACTRSPortal/FACTRS/index.cfm or by
mail to Advisory Committee Oversight
and Management Staff, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, rm. 5103, Silver Spring,
MD 20993–0002. Information about
becoming a member of an FDA advisory
committee can also be obtained by
visiting FDA’s Web site https://
www.fda.gov/AdvisoryCommittees/
default.htm.
FOR FURTHER INFORMATION CONTACT:
Caryn Cohen, Office of Science, Center
for Tobacco Products, Food and Drug
Administration, Center for Tobacco
Products Document Control Center,
Bldg. 71, rm. G335, 10903 New
Hampshire Ave., Silver Spring, MD
20993–0002,1–877–287–1373 (choose
Option 5), FAX: 240–276–3655,
TPSAC@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency intends to add a nonvoting
industry representative to represent the
interests of the small business tobacco
manufacturing industry, to the
following advisory committee (this
position may be filled on a rotating,
sequential basis by representatives of
different small business tobacco
manufacturers based on areas of
expertise relevant to the topics being
considered by the Advisory Committee).
I. Tobacco Products Scientific Advisory
Committee
The Tobacco Products Scientific
Advisory Committee (the Committee)
advises the Commissioner of Food and
Drugs (the Commissioner) or designee in
discharging responsibilities related to
the regulation of tobacco products. The
Committee reviews and evaluates safety,
dependence, and health issues relating
to tobacco products and provides
appropriate advice, information, and
recommendations to the Commissioner.
The Committee includes three
nonvoting members who represent
industry interests. These members
include one representative of the
interests of the tobacco manufacturing
industry, one representative of the
interests of tobacco growers, and one
representative of the interests of the
small business tobacco manufacturing
industry, which may be filled on a
rotating, sequential basis by
representatives of different small
business tobacco manufacturers based
on areas of expertise relevant to the
topics being considered by the Advisory
Committee.
With this notice, nominations are
sought for the following positions: A
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
64605
pool of individuals, with varying areas
of expertise, to represent the interests of
the small business tobacco
manufacturing industry on a rotating,
sequential basis.
II. Selection Procedure
Any small business tobacco
manufacturing industry organization
interested in participating in the
selection of an appropriate nonvoting
member to represent the interests of the
small business tobacco manufacturing
industry, must send a letter stating that
interest to the FDA contact (see FOR
FURTHER INFORMATION CONTACT) within
30 days of publication of this document
(see DATES). Within the subsequent 30
days, FDA will send a letter to each
organization that has expressed an
interest, attaching a complete list of all
such organizations; and a list of all
nominees along with their current
´
´
resumes. The letter will also state that
it is the responsibility of the interested
organizations to confer with one another
and to select a candidate or candidates
(to serve in a pool of individuals, with
varying areas of expertise, to represent
the interests of the small business
tobacco manufacturing industry on a
rotating, sequential basis), within 60
days after the receipt of the FDA letter,
to serve as the nonvoting member to
represent industry interests for the
committee. The interested organizations
are not bound by the list of nominees in
selecting a candidate or candidates.
However, if no individual is selected
within 60 days, the Commissioner will
select the nonvoting member (or pool of
individuals) to represent the small
business tobacco manufacturing
industry interests.
III. Application Procedure
Individuals may self nominate and/or
an organization may nominate one or
more individuals to serve as a nonvoting
industry representative. Contact
information, a current curriculum vitae,
and the name of the committee of
interest should be sent to the FDA
contact person (see FOR FURTHER
INFORMATION CONTACT) within 30 days of
publication of this document (see
DATES). FDA will forward all
nominations to the organizations
expressing interest in participating in
the selection process for the committee.
(Persons who nominate themselves as
nonvoting industry representatives will
not participate in the selection process.)
FDA seeks to include the views of
women and men, members of all racial
and ethnic groups, and individuals with
and without disabilities on its advisory
committees and, therefore encourages
nominations of appropriately qualified
E:\FR\FM\30OCN1.SGM
30OCN1
64606
Federal Register / Vol. 79, No. 210 / Thursday, October 30, 2014 / Notices
candidates from these groups. This
notice is issued under the Federal
Advisory Committee Act (5 U.S.C. app.
2) and 21 CFR part 14, relating to
advisory committees.
Dated: October 24, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–25795 Filed 10–29–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Non-HIV Diagnostics, Food Safety,
Sterilization/Disinfection and
Bioremediation.
Date: November 17–18, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
pandyaga@mai.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Vaccines
Against Microbial Diseases—Special.
Date: November 18–19, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Jian Wang, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
VerDate Sep<11>2014
17:40 Oct 29, 2014
Jkt 235001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: Structural bases of the functions of
RNA-protein machines.
Date: November 19–20, 2014.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Kathryn M Koeller, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, 301–435–
2681, koellerk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Bioengineering Sciences and Technologies:
AREA Review Group 2.
Date: November 19–20, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Ping Fan, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5154,
MSC 7840, Bethesda, MD 20892, 301–408–
9971, fanp@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group;
NeuroAIDS and other End-Organ Diseases
Study Section.
Date: November 20, 2014.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr. Room 3216,
Bethesda, MD 20892, 301–435–1050,
freundr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Asthma, COPD and Host Defense.
Date: November 20–21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Ghenima Dirami, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 240–498–
7546, diramig@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Oncology 1
Basic Translational—Member Conflicts.
Date: November 20, 2014.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
PO 00000
Frm 00044
Fmt 4703
Sfmt 9990
Contact Person: Manzoor Zarger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, zargerma@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Training:
Comparative Medicine.
Date: November 20–21, 2014.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Vascular Regulation and
Hematology.
Date: November 20–21, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–14–
011, Genomic Underpinnings of Response to
Rehabilitation Interventions.
Date: November 20, 2014.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848, Bethesda,
MD 20892, (301) 402–4411,
tianbi@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 24, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–25761 Filed 10–29–14; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\30OCN1.SGM
30OCN1
Agencies
[Federal Register Volume 79, Number 210 (Thursday, October 30, 2014)]
[Notices]
[Pages 64605-64606]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-25795]
[[Page 64605]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0383]
Request for Nominations on the Tobacco Products Scientific
Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting that any
small business tobacco manufacturing industry organizations interested
in participating in the selection of nonvoting industry representatives
to represent the interests of the small business tobacco manufacturing
industry, to serve on the Tobacco Products Scientific Advisory
Committee for the Center for Tobacco Products notify FDA in writing.
FDA is also requesting nominations for nonvoting industry
representatives to be included in a pool of individuals to represent
the interests of the small business tobacco manufacturing industry on
the Tobacco Products Scientific Advisory Committee. A nominee may
either be self-nominated or nominated by an organization to serve as a
nonvoting industry representative. This position may be filled on a
rotating, sequential basis by representatives of different small
business tobacco manufacturers based on areas of expertise relevant to
the topics being considered by the Advisory Committee. Nominations will
be accepted for current vacancies effective with this notice.
DATES: Any small business tobacco manufacturing industry organization
interested in participating in the selection of an appropriate
nonvoting member to represent the interests of the small business
tobacco manufacturing industry, must send a letter stating that
interest to FDA by December 1, 2014 (see sections I and II of this
document for details). Concurrently, nomination materials for
prospective candidates should be sent to FDA by December 1, 2014.
ADDRESSES: All statements of interest from small business tobacco
manufacturing industry organizations interested in participating in the
selection process of nonvoting industry representative nominations
should be sent to Caryn Cohen (see FOR FURTHER INFORMATION CONTACT).
All nominations for nonvoting industry representatives may be submitted
electronically by accessing the FDA Advisory Committee Membership
Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail to Advisory Committee Oversight and
Management Staff, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 32, rm. 5103, Silver Spring, MD 20993-0002. Information
about becoming a member of an FDA advisory committee can also be
obtained by visiting FDA's Web site https://www.fda.gov/AdvisoryCommittees/default.htm.
FOR FURTHER INFORMATION CONTACT: Caryn Cohen, Office of Science, Center
for Tobacco Products, Food and Drug Administration, Center for Tobacco
Products Document Control Center, Bldg. 71, rm. G335, 10903 New
Hampshire Ave., Silver Spring, MD 20993-0002,1-877-287-1373 (choose
Option 5), FAX: 240-276-3655, TPSAC@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The Agency intends to add a nonvoting
industry representative to represent the interests of the small
business tobacco manufacturing industry, to the following advisory
committee (this position may be filled on a rotating, sequential basis
by representatives of different small business tobacco manufacturers
based on areas of expertise relevant to the topics being considered by
the Advisory Committee).
I. Tobacco Products Scientific Advisory Committee
The Tobacco Products Scientific Advisory Committee (the Committee)
advises the Commissioner of Food and Drugs (the Commissioner) or
designee in discharging responsibilities related to the regulation of
tobacco products. The Committee reviews and evaluates safety,
dependence, and health issues relating to tobacco products and provides
appropriate advice, information, and recommendations to the
Commissioner.
The Committee includes three nonvoting members who represent
industry interests. These members include one representative of the
interests of the tobacco manufacturing industry, one representative of
the interests of tobacco growers, and one representative of the
interests of the small business tobacco manufacturing industry, which
may be filled on a rotating, sequential basis by representatives of
different small business tobacco manufacturers based on areas of
expertise relevant to the topics being considered by the Advisory
Committee.
With this notice, nominations are sought for the following
positions: A pool of individuals, with varying areas of expertise, to
represent the interests of the small business tobacco manufacturing
industry on a rotating, sequential basis.
II. Selection Procedure
Any small business tobacco manufacturing industry organization
interested in participating in the selection of an appropriate
nonvoting member to represent the interests of the small business
tobacco manufacturing industry, must send a letter stating that
interest to the FDA contact (see FOR FURTHER INFORMATION CONTACT)
within 30 days of publication of this document (see DATES). Within the
subsequent 30 days, FDA will send a letter to each organization that
has expressed an interest, attaching a complete list of all such
organizations; and a list of all nominees along with their current
r[eacute]sum[eacute]s. The letter will also state that it is the
responsibility of the interested organizations to confer with one
another and to select a candidate or candidates (to serve in a pool of
individuals, with varying areas of expertise, to represent the
interests of the small business tobacco manufacturing industry on a
rotating, sequential basis), within 60 days after the receipt of the
FDA letter, to serve as the nonvoting member to represent industry
interests for the committee. The interested organizations are not bound
by the list of nominees in selecting a candidate or candidates.
However, if no individual is selected within 60 days, the Commissioner
will select the nonvoting member (or pool of individuals) to represent
the small business tobacco manufacturing industry interests.
III. Application Procedure
Individuals may self nominate and/or an organization may nominate
one or more individuals to serve as a nonvoting industry
representative. Contact information, a current curriculum vitae, and
the name of the committee of interest should be sent to the FDA contact
person (see FOR FURTHER INFORMATION CONTACT) within 30 days of
publication of this document (see DATES). FDA will forward all
nominations to the organizations expressing interest in participating
in the selection process for the committee. (Persons who nominate
themselves as nonvoting industry representatives will not participate
in the selection process.)
FDA seeks to include the views of women and men, members of all
racial and ethnic groups, and individuals with and without disabilities
on its advisory committees and, therefore encourages nominations of
appropriately qualified
[[Page 64606]]
candidates from these groups. This notice is issued under the Federal
Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating
to advisory committees.
Dated: October 24, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-25795 Filed 10-29-14; 8:45 am]
BILLING CODE 4164-01-P